Announcement • Mar 31
AB Igrene (publ) has filed a Follow-on Equity Offering in the amount of SEK 27.381089 million. AB Igrene (publ) has filed a Follow-on Equity Offering in the amount of SEK 27.381089 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 49,783,798
Price\Range: SEK 0.55
Transaction Features: Rights Offering Announcement • Mar 25
AB Igrene (publ) to Report Q2, 2026 Results on Apr 23, 2026 AB Igrene (publ) announced that they will report Q2, 2026 results on Apr 23, 2026 Announcement • Dec 18
AB Igrene (publ) to Report Q1, 2026 Results on Jan 16, 2026 AB Igrene (publ) announced that they will report Q1, 2026 results on Jan 16, 2026 Announcement • Sep 18
AB Igrene (publ) to Report Fiscal Year 2025 Results on Oct 17, 2025 AB Igrene (publ) announced that they will report fiscal year 2025 results on Oct 17, 2025 Announcement • Jun 19
AB Igrene (publ) to Report Q3, 2025 Results on Jul 18, 2025 AB Igrene (publ) announced that they will report Q3, 2025 results on Jul 18, 2025 New Risk • Apr 16
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -kr7.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr7.1m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Shareholders have been substantially diluted in the past year (104% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (kr49.8m market cap, or US$5.08m). Announcement • Mar 25
AB Igrene (publ) to Report Q2, 2025 Results on Apr 23, 2025 AB Igrene (publ) announced that they will report Q2, 2025 results on Apr 23, 2025 New Risk • Jan 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Swedish stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (104% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (kr31.7m market cap, or US$2.83m). Announcement • Dec 11
AB Igrene (publ) to Report Q1, 2025 Results on Jan 24, 2025 AB Igrene (publ) announced that they will report Q1, 2025 results on Jan 24, 2025 New Risk • Nov 03
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 104% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Shareholders have been substantially diluted in the past year (104% increase in shares outstanding). Revenue is less than US$1m (kr158k revenue, or US$15k). Market cap is less than US$10m (kr33.3m market cap, or US$3.10m). Announcement • Sep 22
AB Igrene (publ) to Report Fiscal Year 2024 Results on Oct 21, 2024 AB Igrene (publ) announced that they will report fiscal year 2024 results on Oct 21, 2024 New Risk • Jul 23
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -kr2.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr2.5m free cash flow). Share price has been highly volatile over the past 3 months (32% average weekly change). Revenue is less than US$1m (kr158k revenue, or US$15k). Market cap is less than US$10m (kr35.6m market cap, or US$3.31m). Announcement • Jun 20
AB Igrene (publ) to Report Q3, 2024 Results on Jul 19, 2024 AB Igrene (publ) announced that they will report Q3, 2024 results on Jul 19, 2024 Announcement • Mar 21
AB Igrene (publ) to Report Q2, 2024 Results on Apr 19, 2024 AB Igrene (publ) announced that they will report Q2, 2024 results on Apr 19, 2024 Announcement • Dec 24
AB Igrene (publ), Annual General Meeting, Jan 22, 2024 AB Igrene (publ), Annual General Meeting, Jan 22, 2024. Announcement • Dec 21
AB Igrene (publ) to Report Q1, 2024 Results on Jan 19, 2024 AB Igrene (publ) announced that they will report Q1, 2024 results on Jan 19, 2024 Announcement • Sep 25
AB Igrene (publ) to Report Fiscal Year 2023 Results on Oct 23, 2023 AB Igrene (publ) announced that they will report fiscal year 2023 results on Oct 23, 2023 Announcement • Jun 18
AB Igrene (publ) to Report Q3, 2023 Results on Jul 17, 2023 AB Igrene (publ) announced that they will report Q3, 2023 results on Jul 17, 2023 Announcement • Dec 26
AB Igrene (publ), Annual General Meeting, Jan 23, 2023 AB Igrene (publ), Annual General Meeting, Jan 23, 2023. Announcement • Dec 22
AB Igrene (publ) to Report Q1, 2023 Results on Jan 20, 2023 AB Igrene (publ) announced that they will report Q1, 2023 results on Jan 20, 2023 Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Oct 26
Full year 2022 earnings released: kr0.15 loss per share (vs kr0.26 loss in FY 2021) Full year 2022 results: kr0.15 loss per share (improved from kr0.26 loss in FY 2021). Net loss: kr4.98m (loss narrowed 13% from FY 2021). Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings. Announcement • Jun 21
AB Igrene (publ) to Report Q3, 2022 Results on Jul 19, 2022 AB Igrene (publ) announced that they will report Q3, 2022 results on Jul 19, 2022 Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Mar 23
AB Igrene (publ) to Report Q2, 2022 Results on Apr 19, 2022 AB Igrene (publ) announced that they will report Q2, 2022 results on Apr 19, 2022 Is New 90 Day High Low • Mar 10
New 90-day low: kr0.66 The company is down 32% from its price of kr0.97 on 09 December 2020. The Swedish market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is up 8.0% over the same period. Is New 90 Day High Low • Jan 07
New 90-day low: kr0.87 The company is down 28% from its price of kr1.20 on 09 October 2020. The Swedish market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is up 3.0% over the same period. Announcement • Dec 24
AB Igrene (publ) to Report Q1, 2021 Results on Jan 22, 2021 AB Igrene (publ) announced that they will report Q1, 2021 results on Jan 22, 2021 Is New 90 Day High Low • Dec 02
New 90-day low: kr0.95 The company is down 18% from its price of kr1.15 on 03 September 2020. The Swedish market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is up 2.0% over the same period. Reported Earnings • Oct 22
Full year earnings released - kr0.33 loss per share Over the last 12 months the company has reported total losses of kr7.26m, with losses narrowing by 19% from the prior year. Announcement • Oct 19
AB Igrene (publ) to Report Fiscal Year 2020 Results on Oct 20, 2020 AB Igrene (publ) announced that they will report fiscal year 2020 results on Oct 20, 2020 Announcement • Jun 22
AB Igrene (publ) to Report Q3, 2020 Results on Jul 20, 2020 AB Igrene (publ) announced that they will report Q3, 2020 results on Jul 20, 2020 